Literature DB >> 11098855

Oxidation of cellular thiols by hydroxyethyldisulphide inhibits DNA double-strand-break rejoining in G6PD deficient mammalian cells.

I S Ayene1, C J Koch, S W Tuttle, T D Stamato, M L Perez, J E Biaglow.   

Abstract

PURPOSE: We investigated the effect of protein- and non protein-thiol oxidation on DNA double-strand-break (DSB) rejoining after irradiation and its relevance in the survival of CHO cells.
MATERIALS AND METHODS: We used mutant cells null for glucose 6 phosphate dehydrogenase (G6PD) activity since reducing equivalents, required for reduction of oxidized thiols, are typically generated through G6PD regulated production of NADPH. Cellular thiols were oxidized by pre-incubating the cells with hydroxyethyldisulphide (HEDS), the oxidized form of mercaptoethanol (ME). The concentrations of the intracellular and extracellular non-protein thiols (NPSH), glutathione, cysteine and mercaptoethanol were quantitated by HPLC. Protein thiols (PSH) were estimated using Ellman's reagent. Cell survival was determined by clonogenic assay. The induction and rejoining of DSB in cells was quantitated by Pulse Field Gel Electrophoresis after exposure to ionizing radiation.
RESULTS: Much lower bioreduction of HEDS was found in the G6PD deficient mutants (E89) than in the wild-type cells (K1). A 1 h treatment of E89 cells with HEDS produced almost complete depletion of non-protein thiol (NPSH) and a 26% decrease in protein thiols. Only minor changes were found under similar conditions with K1 cells. When exposed to gamma radiation in the presence of HEDS, the G6PD null mutants exhibited a higher cell killing and decreased rate and extent of rejoining of DSB than were observed in K1 cells. Moreover, when the G6PD deficient cells were transfected with the gene encoding wild-type G6PD (A1A), they recovered close to wild-type cellular thiol status, cell survival and DSB rejoining.
CONCLUSIONS: These results suggest that a functioning oxidative pentose phosphate pathway is required for DSB rejoining in cells exposed to a mild thiol oxidant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11098855     DOI: 10.1080/09553000050176289

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  7 in total

1.  Kinetic analysis of the Ku-DNA binding activity reveals a redox-dependent alteration in protein structure that stimulates dissociation of the Ku-DNA complex.

Authors:  Brooke J Andrews; Jason A Lehman; John J Turchi
Journal:  J Biol Chem       Date:  2006-03-13       Impact factor: 5.157

2.  Hydroxyethyl disulfide as an efficient metabolic assay for cell viability in vitro.

Authors:  Jie Li; Donglan Zhang; Kathleen M Ward; George C Prendergast; Iraimoudi S Ayene
Journal:  Toxicol In Vitro       Date:  2012-01-31       Impact factor: 3.500

3.  A bioactive probe of the oxidative pentose phosphate cycle: novel strategy to reverse radioresistance in glucose deprived human colon cancer cells.

Authors:  Jie Li; Kathleen M Ward; Donglan Zhang; Eswarkumar Dayanandam; Albert S Denittis; George C Prendergast; Iraimoudi S Ayene
Journal:  Toxicol In Vitro       Date:  2012-08-16       Impact factor: 3.500

4.  A bioactive probe for glutathione-dependent antioxidant capacity in breast cancer patients: implications in measuring biological effects of arsenic compounds.

Authors:  Jie Li; Donglan Zhang; Pearl A Jefferson; Kathleen M Ward; Iraimoudi S Ayene
Journal:  J Pharmacol Toxicol Methods       Date:  2013-10-20       Impact factor: 1.950

5.  ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair.

Authors:  Claudia Cosentino; Domenico Grieco; Vincenzo Costanzo
Journal:  EMBO J       Date:  2010-12-14       Impact factor: 11.598

Review 6.  Protein oxidation, UVA and human DNA repair.

Authors:  Peter Karran; Reto Brem
Journal:  DNA Repair (Amst)       Date:  2016-05-20

7.  Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer.

Authors:  James DuHadaway; George C Prendergast
Journal:  Oncotarget       Date:  2016-02-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.